Aromatic amines and human urinary bladder cancer: Exposure sources and epidemiology

Journal of Environmental Science and Health - Part C Environmental Carcinogenesis and Ecotoxicology Reviews

Volumn 21, Issue 1, 2003, Pages 29-43

  Talaska, Glenn ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Aromatic amines; Hair dyes; Human; N Acetyltransferase; Occupational exposure; Tobacco smoke; Urinary bladder cancer

Indexed keywords

AMINES; BIOMARKERS; DYES; EPIDEMIOLOGY; HEALTH RISKS; STRUCTURE (COMPOSITION);

BIOLOGICAL EFFECTS;

TUMORS;

2 AMINO 4 NITROPHENOL; 2 METHYLANILINE; 2 NAPHTHYLAMINE; 2,4 DIAMINOANISOLE; 2,6 DIMETHYLANILINE; 4 BIPHENYLAMINE; 4 CHLOROANILINE; 4 CRESIDINE; 4,4 METHYLENEBIS(2 CHLOROANILINE); ACYLTRANSFERASE; ANILINE DERIVATIVE; AROMATIC AMINE; BENZIDINE; CARCINOGEN; CIGARETTE SMOKE; DNA; EXPLOSIVE; FERTILIZER; HAIR DYE; N PHENYL 2 NAPHTHYLAMINE; POLYMER; RUBBER; UNCLASSIFIED DRUG;

ACETYLATION; ALKYLATION; ANIMAL MODEL; BLADDER CANCER; CANCER RISK; CHEMICAL STRUCTURE; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA BINDING; ENVIRONMENTAL EXPOSURE; ENZYME ACTIVITY; HAIR COLOR; HAIRDRESSER; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; MUTAGENICITY; NONHUMAN; OCCUPATIONAL EXPOSURE; REVIEW; RISK ASSESSMENT; TOBACCO; URINARY TRACT CANCER;

AMINES; BIOLOGICAL MARKERS; CARCINOGENS; EPIDEMIOLOGIC STUDIES; HAIR DYES; HUMANS; SMOKING; TOBACCO SMOKE POLLUTION; URINARY BLADDER NEOPLASMS;

ANIMALIA; NICOTIANA TABACUM;

EID: 0037604848     PISSN: 10590501     EISSN: None     Source Type: Journal    
DOI: 10.1081/GNC-120021372     Document Type: Review

References (57)

1. Rehn L, Blasengeschwülste bei anilinarbeitern. Archiv für Klinische Chiruge 1895; 50:588-600.
2. Chenowith LB, Machle W. Industrial Hygiene: A Handbook of Hygiene and Toxicology for Engineers and Plant Managers; New York: F.S. Crofts and Co., 1938:146-147.
3. Hamblin DO. Aromatic nitro and amino compounds. In: Patty FA, Fassett DW, Irish DD, eds. Industrial Hygiene and Toxicology. Vol. 2, 2nd ed. New York: John Wiley and Sons, 2123-2126.
4. Polyurethane Manufacturers Association website, http://www.mocahome.org/index.html
5. Zavon M, Hoegg U, Bingham E. Benzidine exposure as a cause of bladder tumors. Arch Environ Health 1973; 27:1-7.
6. Bi W, Hayes RB, Feng P, Qi Y, You X, Zhen J, Zheng M, Qu B, Fu Z, Chen M, Chein HT, Blot WJ. Mortality and cancer incidence of bladder cancer of benzidine-exposed workers in China. Am J Ind Med 1992; 21:481-489.
7. Rothman N, Bhatnagar VK, Hayes RB, Kashyap R, Parikh DJ, Kashyap SK, Schulte PA, Butler MA, Jaeger M, Talaska G. The impact of interindividual variability in N-acetyltransferase activity on benzidine urinary metabolites and urothelial DNA adducts in exposed workers. Proc Natl Acad Sci (USA) 1996; 93:5084-5089.
8. Talaska G, Schamer M, Casetta G, Tizzani A, Vineis P. Carcinogen-DNA adducts in bladder biopsies and urothelial cells: a risk assessment exercise. Cancer Letts 1994; 84:93-97.
9. Talaska G, Al-Juburi AZSS, Kadlubar FF. Smoking-related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct. Proc Natl Acad Sci (USA) 1991; 88:5350-5354.
10. Gado-Dominguez M, Chan KK, Ross RK, Yu M. Permanent hair dyes and bladder cancer risk. Int J Risk Assess 2001; 94:905-906.
11. Weisburger JH. Past, present and future role of carcinogenic and mutagenic N-substituted aryl compounds in human cancer causation. In: King CM, Romano LJ, Scheutzle D, eds. Carcinogenic and Mutagenic Response to Aromatic Amines and Nitroarenes. New York: Elsevier, 3-21.
12. Kadlubar FF. DNA adducts of carcinogenic aromatic amines. In: Hemminki K, Dipple A, Shuker DEG, Kadlubar FF, Segerbäck D, Bartsch H, eds. DNA Adducts: Identification and Biological Significance. Lyon, France: IARC Scientific Publications number 125, International Agency for Research on Cancer, 1994.
13. Franke R, Gruska A, Giuliani V, Benigni R. Prediction of rodent carcinogenicity of aromatic amines: a quantitative structure-activity relationship model. Carcinogenesis 2001; 22:1561-1571.
14. Benigni R, Passerini L. Carcinogenicity of the aromatic amines: from structureactivity relationships to mechanisms of action and risk assessment. Mutat Res 2002; 511:191-206.
15. Albert RE. Unifying the standard setting process for carcinogens and non-carcinogens. Appld Occup Environ Hyg 1999; 14:742-747.
16. Osterman-Golkar S, Ehrenberg L. Dosimetry of electrophilic compounds by means of hemoglobin alkylation. Ann Rev Public Health 1983; 4:397-402.
17. Calvert G, Talaska G, Mueller C, Fajen J, Fleming L, Briggle T. Evaluation of biological markers among US fumigation workers exposed to methyl bromide. Mutat Res 1998; 417:115-128.
18. Hedenstedt A, Rannug U, Ramel C, Wachmeister CA. Mutagenicity and metabolism studies of 12 thiuram and dithiocarbamate compounds used as accelerators in the rubber industry. Mutat Res 1982; 68:313-325.
19. Nony CR, Bowman MC, Cairn T, Lowry LK, Tolos WP. Metabolism studies of azo dye and pigments in the hamster based on analysis of the urine for potentially carcinogenic aromatic amine metabolites. J Anal Chem 1980; 4:63-67.
20. 6ppm)/760 mm Hg
21. NIOSH National Institute for Occupational Safety and Health, Pocket Guide to Chemical Hazards, U.S. Department of Health and Human Services, Center for Disease Control, 1994, Government Printing Office, Washington, D.C.
22. American Conference of Governmental Industrial Hygienists (ACGIH) Documentation of the TLVs and BEIs, 8th Ed. Cincinnati, Ohio, 2002.
23. Moore RM, Wolff BS, Stein HP, Thomas AW, Finklea JF. Metabolic precursors of a known human carcinogen. Science 1977; 195:344-346.
24. Morbidity and Mortality Weekly Reports. 2001; 51:642-646.
25. National Cancer Institute Seer Program. http://surveillance.cancer.gov/statistics/.2002.
26. Patrianakos C, Hoffman D. Analysis of tobacco smoke components. J Anal Toxicol 1979; 3:150-154.
27. United States International Trade Commission website, http://www.usitc.gov/.
28. Chemical Industry website, http://www.chemchannels.com/chemchannel/default.asp/.
29. Ward E, Halperin W, Thun M, Grossman HB, Fink B, Koss L, Osario AM, Schulte P. Bladder tumors in two young males occupationally exposed to MBOCA. Am J Ind Med 1988; 14:267-272.
30. Ward E, Halperin W, Thun M, Grossman HB, Fink B, Koss L, Osario AM, Schulte P. Screening workers exposed to 4,4′-methylene bis(2-chloroaniline) for bladder cancer by cytoscopy. J Occup Med 1990; 32:865-868.
31. Ward EM, Sabbioni G, DeBord DG, Teass AW, Brown K, Talaska G, Roberts D, Ruder A, Streicher RP. Biological monitoring of aromatic amine exposures at a chemical plant with a known bladder cancer excess. J Natl Cancer Instit 1996; 88:1046-1052.
32. U.S. National Library of Medicine: Aniline. In: Hazardous Substances Data Bank. Toxicological data network (TOXNET) Online at http://toxnet.nlm. nih.gov/.
33. Kayshup SK. Past Director of Indian Institute for Occupational Safety and Health. Presentation to the University of Cincinnati Department of Environmental Health, March, 1996.
34. Vineis P. Epidemiology of cancer from exposure to aromatic amines. Environ Health Perspect 1994; 102:7-10.
35. Melick WF, Escue HM, Naryka J, Mezera RA, Wheeler EP. The first reported cases of human bladder tumors due to a new carcinogen-xenylamine. J Urol 1955; 74:760-766.
36. Vineis P, Simonato L. Proportion of lung and bladder cancers in males resulting from occupation: a systematic approach. Arch Environ Health 1991; 46:7-15.
37. La Vecchia C, Tavani A. Epidemiological evidence on hair dyes and the risk of cancer in humans. Euro J Cancer Prev 1995; 4:31-43.
38. Thun MJ, Altekruse SF. Hair dye use and risk of fatal cancers in U.S. women. J Nat Cancer Inst 1994; 86:210-215.
39. Dressler W. Toxicologist, Clairol Division of Proctor and Gamble Co., personal communication.
40. Gado-Dominguez M, Chan KK, Ross RK, Yu MC. Permanent hair dyes and bladder cancer. Int J Cancer 2001; 94:905-906.
41. Henley SJ, Thun MJ. Use of permanent hair dyes and bladder cancer risk. Int J Cancer 2001; 94:903-904.
42. Miller AB, Bartsch H. Hair dye use and bladder cancer. Int J Cancer 2001; 94:902-902.
43. Lower GM, Nilsson T, Nelson CE, Wolf H, Gamsky TE, Bryant GT. N-Acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Environ Health Perspect 1979; 29:71-79.
44. Vineis P, Malars N, Lang M, D'Errico A, Caporaso N, Cuzick J, Boffetta P. Metabolic Polymorphisms and Susceptibility to Cancer. IARC Scientific Publications, 1999.
45. Hearse DJ, Weber WW. Multiple N-acetyltransferases and drug metabolism. Biochem J 1973; 132:519-526.
46. Hein DW, Doll MA, Fretland AJ, Leff MA, Webb SJ, Xiao GH, Devanaboyina U-S, Nangju NA, Feng Y. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev 2000; 9:29-42.
47. Hein DW. N-Acetyltransferase nomenclature website, http://www.louisville.edu/medschool/pharmacology/NAT.html, 2002.
48. Hein DW, Doll MA, Rustan TD, Ferfuson RJ. Metabolic activation of N-hydroxylarylamines and N-hydroxylarylamides by 16 recombinant human NAT2 allozymes: effects of 7 specific NAT2 nucleic acid substitutions. Cancer Res 1995; 55:3531-3536.
49. Frederick CB, Weiss CC, Flammang TJ, Martin CN, Kadlubar FF. Hepatic N-oxidation, acetyltransfer and DNA binding of the acetylated metabolites of the carcinogen, benzidine. Carcinogenesis 1985; 6:959-965.
50. Yoneyama K, Matsumura F. Microbial metabolism of 4,4′-methylene bis(2-chloroaniline). Arch Environ Contain Toxicol 1984; 13:501-507.
51. Taylor JA, Umbach DM, Stephens E, Castranio T, Paulson D, Robertson C, Mohler JL, Bell DA. The role of N-acetylation polymorphisms in smokingassociated bladder cancer: evidence of a gene-gene-exposure three way interaction. Cancer Res 1998; 58:3603-3610.
52. Kadlubar FF, Badawi AF. Genetic susceptibility and DNA adduct formation in human urinary bladder carcinogenesis. Toxicol Lett 1995; 82:627-632.
53. Skipper PL, Tannenbaum SR. Protein adducts in the molecular dosimetry of chemical carcinogens. Carcinogenesis 1990; 11:507-518.
54. Marcus PM, Hayes RB, Vineis P, Garcia-Closas M, Caporaso NE, Autrup H, Branch R, Brockmöller J, Ishazaki T, Karakaya AE, Ladero J, Mommsen S, Okkels H, Romkes M, Roots I, Rothman N. Cigarette smoking, N-acetyl-transferase 2 acetylation status, and bladder cancer risk: a case-series meta-analysis of a gene-environment interaction. Cancer Epidemiol. Biomarkers Prev 2000; 9:461-467.
55. Vineis P, Marinelli D, Autrup H, Brockmöller J, Cascorbi I, Daly AK, Golka K, Okkels H, Risch A, Rothman N, Sim E, Taili E. Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotypebased studies. Cancer Epidemiol Biomarkers Prev 2001; 10:1249-1253.
56. Golka K, Prior V, Blaszkewicz M, Bolt HM. The enhanced bladder cancer susceptibility of NAT2 slow acetylators toward aromatic amines: a review considering ethnic differences. Toxicol Letts 2002; 229-241.
57. Bartsch H, Caporaso N, Coda M, Kadlubar FF, Malaveille C, Skipper P, Talaska G, Tannenbaum SR, Vineis P. Carcinogen-hemoglobin adducts, urine mutagenicity and metabolic phenotype in active and passive cigarette smokers. J Natl Cancer Inst 1991; 82:1826-1831.